140 related articles for article (PubMed ID: 23416070)
1. Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism.
von Meyenn F; Porstmann T; Gasser E; Selevsek N; Schmidt A; Aebersold R; Stoffel M
Cell Metab; 2013 Mar; 17(3):436-47. PubMed ID: 23416070
[TBL] [Abstract][Full Text] [Related]
2. Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.
Kim H; Mendez R; Chen X; Fang D; Zhang K
Mol Cell Biol; 2015 Dec; 35(24):4121-34. PubMed ID: 26438600
[TBL] [Abstract][Full Text] [Related]
3. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.
Wolfrum C; Asilmaz E; Luca E; Friedman JM; Stoffel M
Nature; 2004 Dec; 432(7020):1027-32. PubMed ID: 15616563
[TBL] [Abstract][Full Text] [Related]
4. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion.
Wolfrum C; Stoffel M
Cell Metab; 2006 Feb; 3(2):99-110. PubMed ID: 16459311
[TBL] [Abstract][Full Text] [Related]
5. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 mediates FOXA2 breakdown by deacetylation in a nutrient-dependent manner.
van Gent R; Di Sanza C; van den Broek NJ; Fleskens V; Veenstra A; Stout GJ; Brenkman AB
PLoS One; 2014; 9(5):e98438. PubMed ID: 24875183
[TBL] [Abstract][Full Text] [Related]
7. Metformin impairs systemic bile acid homeostasis through regulating SIRT1 protein levels.
Chen Q; Yang X; Zhang H; Kong X; Yao L; Cui X; Zou Y; Fang F; Yang J; Chang Y
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):101-112. PubMed ID: 27816442
[TBL] [Abstract][Full Text] [Related]
8. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.
Kemper JK; Xiao Z; Ponugoti B; Miao J; Fang S; Kanamaluru D; Tsang S; Wu SY; Chiang CM; Veenstra TD
Cell Metab; 2009 Nov; 10(5):392-404. PubMed ID: 19883617
[TBL] [Abstract][Full Text] [Related]
9. SIK2 regulates fasting-induced PPARα activity and ketogenesis through p300.
Zhang ZN; Gong L; Lv S; Li J; Tai X; Cao W; Peng B; Qu S; Li W; Zhang C; Luan B
Sci Rep; 2016 Mar; 6():23317. PubMed ID: 26983400
[TBL] [Abstract][Full Text] [Related]
10. Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver.
Nakamura K; Moore R; Negishi M; Sueyoshi T
J Biol Chem; 2007 Mar; 282(13):9768-9776. PubMed ID: 17267396
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human lipoprotein lipase gene by the forkhead box transcription factor FOXA2/HNF-3β in hepatic cells.
Kanaki M; Kardassis D
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):327-336. PubMed ID: 28126606
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism.
Zhang L; Yao W; Xia J; Wang T; Huang F
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995792
[TBL] [Abstract][Full Text] [Related]
13. An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha.
Wilson BJ; Tremblay AM; Deblois G; Sylvain-Drolet G; Giguère V
Mol Endocrinol; 2010 Jul; 24(7):1349-58. PubMed ID: 20484414
[TBL] [Abstract][Full Text] [Related]
14. Foxa2 may modulate hepatic apoptosis through the cIAP1 pathway.
Wang K; Brems JJ; Gamelli RL; Holterman AX
Cell Signal; 2013 Apr; 25(4):867-74. PubMed ID: 23275033
[TBL] [Abstract][Full Text] [Related]
15. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.
Stankovic-Valentin N; Deltour S; Seeler J; Pinte S; Vergoten G; Guérardel C; Dejean A; Leprince D
Mol Cell Biol; 2007 Apr; 27(7):2661-75. PubMed ID: 17283066
[TBL] [Abstract][Full Text] [Related]
16. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely independent of Foxa2.
Rubins NE; Friedman JR; Le PP; Zhang L; Brestelli J; Kaestner KH
Mol Cell Biol; 2005 Aug; 25(16):7069-77. PubMed ID: 16055718
[TBL] [Abstract][Full Text] [Related]
18. Foxa2 acts as a co-activator potentiating expression of the Nurr1-induced DA phenotype via epigenetic regulation.
Yi SH; He XB; Rhee YH; Park CH; Takizawa T; Nakashima K; Lee SH
Development; 2014 Feb; 141(4):761-72. PubMed ID: 24496614
[TBL] [Abstract][Full Text] [Related]
19. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
Ray S; Boldogh I; Brasier AR
Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.
Zhao X; Sternsdorf T; Bolger TA; Evans RM; Yao TP
Mol Cell Biol; 2005 Oct; 25(19):8456-64. PubMed ID: 16166628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
